News
Emcure Pharmaceuticals consolidated net profit rises 33.73% in the September 2026 quarter
03-Nov-2026 | 15:12
Sales rise 24.26% to Rs 2820.47 crore
Net profit of Emcure Pharmaceuticals rose 33.73% to Rs 325.57 crore in the quarter ended September 2026 as against Rs 243.46 crore during the previous quarter ended September 2025. Sales rose 24.26% to Rs 2820.47 crore in the quarter ended September 2026 as against Rs 2269.82 crore during the previous quarter ended September 2025.
| Particulars | Quarter Ended | ||
| Sep. 2026 | Sep. 2025 | % Var. | |
| Sales | 2820.47 | 2269.82 | 24 |
| OPM % | 20.84 | 20.95 | - |
| PBDT | 555.52 | 446.06 | 25 |
| PBT | 445.85 | 341.42 | 31 |
| NP | 325.57 | 243.46 | 34 |
Powered by Capital Market - Live News